pyrrolo(1,2-a)quinoxaline has been researched along with quinoxalines in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, D; Yuan, Q | 1 |
| Desplat, V; Fabre, SB; Forfar, I; Grellier, P; Guillon, J; Jarry, C; Millet, P; Moreau, S; Mouray, E; Parzy, D; Sinou, V | 1 |
| Kavthe, RD; Patil, NT; Shinde, VS; Sridhar, B | 1 |
| Belisle-Fabre, S; Déléris, G; Desplat, V; Forfar, I; Gosmann, G; Grellier, P; Guillon, J; Jarry, C; Le-Naour, A; Léger, JM; Moreau, S; Mouray, E; Mullié, C; Pinaud, N; Ravanello, F; Sonnet, P | 1 |
| Jiang, H; Lin, D; Liu, G; Liu, H; Wang, J; Zhang, L; Zhou, Y | 1 |
| Huang, A; Liu, F; Liu, Y; Ma, C; Zhan, C | 1 |
| Ammermann, S; du Mont, WW; Hrib, C; Johannes, HH; Jones, PG; Kowalsky, W | 1 |
| Alvarez, L; Baratin, S; Bollacke, A; Desplat, V; Guillon, J; Jose, J; Le Borgne, M; Marchivie, M; Moreau, S; Pecci, A; Pinaud, N; Rimbault, C; Roche, S; Savrimoutou, S | 1 |
| Bae, M; He, Z; Jamison, TF; Wu, J | 1 |
| Duan, T; Liu, H; Ma, C; Xie, C; Zhang, Z | 1 |
| Li, J; Liu, Q; Liu, T; Ma, N; Zhang, G; Zhang, Z | 1 |
| Chua, KF; Kambach, C; Li, TM; Mai, A; Meleshin, M; Rotili, D; Schutkowski, M; Steegborn, C; You, W | 1 |
| An, Q; Deng, Y; Liu, P; Luo, Y; Sang, Z; Tang, Y; Wang, T; Yang, T; Yang, Y; Zhang, T | 1 |
| Biroccio, A; Ciriolo, MR; Del Bufalo, D; Di Leo, L; Iachettini, S; Leonetti, C; Lucidi, A; Mai, A; Rizzo, A; Rotili, D; Salvati, E; Steegborn, C; Trisciuoglio, D; Zizza, P | 1 |
| Alajarín, R; de Pascual-Teresa, B; Di Geronimo, B; García-Marín, J; Griera, M; Mendicuti, F; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Sánchez-Alonso, P; Vaquero, JJ | 1 |
| Alajarín, R; García-Marín, J; Griera, M; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Vaquero, JJ | 1 |
| Alajarín, R; García-Marín, J; Griera, M; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Sánchez-Alonso, P; Vaquero, JJ | 1 |
| Bolinger, AA; Chen, H; Li, J; Liu, G; Liu, H; Shi, PY; Shi, S; Xie, X; Xu, J; Zhang, W; Zhou, J | 1 |
18 other study(ies) available for pyrrolo(1,2-a)quinoxaline and quinoxalines
| Article | Year |
|---|---|
A one-pot coupling/hydrolysis/condensation process to pyrrolo[1,2-a]quinoxaline.
Topics: Hydrolysis; Molecular Structure; Pyrroles; Quinoxalines | 2008 |
New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity.
Topics: Amines; Animals; Antimalarials; Cell Line; Cell Survival; Ferrous Compounds; Humans; Hydrophobic and Hydrophilic Interactions; Metallocenes; Molecular Structure; Plasmodium falciparum; Pyrroles; Quinoxalines; Structure-Activity Relationship | 2008 |
Pt(IV)-catalyzed hydroamination triggered cyclization: a strategy to fused pyrrolo[1,2-a]quinoxalines, indolo[1,2-a]quinoxalines, and indolo[3,2-c]quinolines.
Topics: Amination; Catalysis; Cyclization; Heterocyclic Compounds; Indoles; Molecular Structure; Platinum; Pyrroles; Quinolines; Quinoxalines; Stereoisomerism | 2010 |
New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part II.
Topics: Antimalarials; Cell Line; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ferrous Compounds; Humans; Metallocenes; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrroles; Quinoxalines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Synthesis of Pyrrolo[1,2-a]quinoxalines via gold(I)-mediated cascade reactions.
Topics: Gold; Pyrroles; Quinoxalines; Temperature | 2011 |
One-pot synthesis of pyrrolo[1,2-a]quinoxalines.
Topics: Crystallography, X-Ray; Models, Molecular; Molecular Structure; Pyrroles; Quinoxalines; Stereoisomerism | 2011 |
Pyrrolo[1,2-a]quinoxalines: novel synthesis via annulation of 2-alkylquinoxalines.
Topics: Alkylation; Glycerol; Models, Molecular; Molecular Structure; Pyrroles; Quinoxalines | 2012 |
Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2.
Topics: Casein Kinase II; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrroles; Quinoxalines; Structure-Activity Relationship | 2013 |
Synthesis of highly functionalized polycyclic quinoxaline derivatives using visible-light photoredox catalysis.
Topics: Catalysis; Cyanides; Cyclization; Light; Oxidation-Reduction; Polycyclic Compounds; Pyrroles; Quinoxalines | 2014 |
One-Pot Synthesis of Pyrrolo[1,2-a]quinoxaline Derivatives via a Copper-Catalyzed Aerobic Oxidative Domino Reaction.
Topics: Catalysis; Copper; Molecular Structure; Organometallic Compounds; Oxidation-Reduction; Pyrroles; Quinoxalines | 2015 |
Iron-Catalyzed Intramolecular C(sp(2))-N Cyclization of 1-(N-Arylpyrrol-2-yl)ethanone O-Acetyl Oximes toward Pyrrolo[1,2-a]quinoxaline Derivatives.
Topics: Catalysis; Cyclization; Iron; Molecular Structure; Oximes; Pyrroles; Quinoxalines | 2015 |
Structural Basis of Sirtuin 6 Activation by Synthetic Small Molecules.
Topics: Humans; Models, Molecular; Molecular Structure; Pyrroles; Quinoxalines; Sirtuins; Small Molecule Libraries | 2017 |
Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrroles; Quinoxalines; Structure-Activity Relationship | 2018 |
Pharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells.
Topics: Acetylation; AMP-Activated Protein Kinases; Apoptosis; Autophagosomes; Autophagy; Autophagy-Related Protein-1 Homolog; Cell Cycle; Cell Proliferation; Enzyme Activation; HCT116 Cells; HeLa Cells; Histones; Humans; Intracellular Signaling Peptides and Proteins; Neoplasms; Pyrroles; Quinoxalines; Reactive Oxygen Species; Signal Transduction; Sirtuins | 2018 |
Pyrrolo[1,2-a]quinoxalines: Insulin Mimetics that Exhibit Potent and Selective Inhibition against Protein Tyrosine Phosphatase 1B.
Topics: Animals; Cell Differentiation; Cell Line; Cell Survival; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Hep G2 Cells; Humans; Insulin; Mice; Models, Molecular; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrroles; Quinoxalines; Structure-Activity Relationship | 2020 |
A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core.
Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrroles; Quinoxalines; Structure-Activity Relationship | 2021 |
Pyrrolo[1,2-a]quinoxal-5-inium salts and 4,5-dihydropyrrolo[1,2-a]quinoxalines: Synthesis, activity and computational docking for protein tyrosine phosphatase 1B.
Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrroles; Quinoxalines; Salts; Structure-Activity Relationship | 2021 |
Design, synthesis, and pharmacological evaluations of pyrrolo[1,2-a]quinoxaline-based derivatives as potent and selective sirt6 activators.
Topics: COVID-19; Humans; Quinoxalines; SARS-CoV-2; Sirtuins | 2023 |